Prostate Artery Embolization
Proud partner of the PAE pioneers
Interview with Dr. Shivank Bhatia:
Prostate Artery Embolization at University of Miami
“We receive excellent imaging which supports guidance into the vessel.”1
The PAE program at UHealth shows what can be achieved with research, teamwork, cutting-edge technology and great passion for improving patients’ lives.
Interview with Prof. Francisco Cesar Carnevale:
Angiography offers hope for patients suffering from prostate-related urinary disorders
“syngo DynaCT is the most important software for the embolization procedure. It identifies the arteries feeding the prostate, gives me an idea of the percentage of the prostate I am treating, and – even more importantly – helps me avoid non-targeted embolization.”1
A minimally invasive catheterization technique known as prostatic artery embolization shows promise as an outpatient treatment for patients suffering from increasingly prevalent prostate hyperplasia. Pioneered by Prof. Francisco Cesar Carnevale, the procedure began U.S. Food and Drug Administration approved trials in twelve centers in the USA and Europe in fall 2014.
Interview with Prof. Marc Sapoval, and Dr. Olivier Pellerin:
The benefits of PAE over TURP: “Fewer minor and major complications.”
“In the context of the very complex pelvic vessel anatomy, access path planning and guidance during catheter navigation is a very much desired support functionality. This is where syngo Embolization Guidance comes into play as a navigation tool to the prostate. It helps speed up the procedure and thereby facilitates reduction of fluoroscopy time and contrast material.”1
Marc Sapoval, MD, PhD, and Olivier Pellerin, MD, talk about the practical aspects of prostate artery embolization to treat benign prostatic hyperplasia.
Using DynaCT to avoid non-target embolizations
Prof. Francisco Cesar Carnevale (at CIRSE 2014) explains how DynaCT helped him to avoid complications during the PAE procedure:
“…at that time, when we were not using DynaCT, we have observed some complications, and some serious complications related to non-target embolisations. … Since we have used DynaCT, we have seen no complications.”1
Using low dose DynaCT and slab-mode during prostate artery embolization
Prof. Marc Sapoval shared his experience of using DynaCT during the PAE procedure:
“…(DynaCT on) the Artis system is very useful, because it allows you to control the position of the catheter and is helpful to accessing the appropriate artery, checking where the embolization site is and to make sure that only the lobe of the prostate is embolised and no other important organs could be damaged during the intervention.”1
1The statements by Siemens’ customers described herein are based on results that were achieved in the customer’s unique setting. Since there is no “typical” hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results.